Compare · PALI vs TIL
PALI vs TIL
Side-by-side comparison of Palisade Bio Inc. (PALI) and Instil Bio Inc. (TIL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PALI and TIL operate in Biotechnology: Biological Products (No Diagnostic Substances) (Health Care), so they compete in similar markets.
- PALI is the larger of the two at $342.0M, about 6.8x TIL ($50.3M).
- PALI has hit the wire 8 times in the past 4 weeks while TIL has been quiet.
- TIL has more recent analyst coverage (10 ratings vs 7 for PALI).
- Company
- Palisade Bio Inc.
- Instil Bio Inc.
- Price
- -
- -
- Market cap
- $342.0M
- $50.3M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- News (4w)
- 8
- 0
- Recent ratings
- 7
- 10
Palisade Bio Inc.
Palisade Bio, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzyme inhibitor intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress, such as results from reduced blood flow to the intestine, infections, and surgery. The company was founded in 2005 and is based in Carlsbad, California.
Instil Bio Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small cell lung cancer, head and neck squamous cell carcinoma, and cervical cancer; and ITIL-306 (FOLR1) with indications, including gynecological, non-small cell lung cancer, and others. The company was incorporated in 2018 and is based in Dallas, Texas.
Latest PALI
- Director Baltera Robert Jr. bought $88,698 worth of shares (45,000 units at $1.97), increasing direct ownership by 11% to 461,904 units (SEC Form 4)
- Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
- Director Baltera Robert Jr. bought $102,084 worth of shares (50,000 units at $2.04), increasing direct ownership by 14% to 416,904 units (SEC Form 4)
- Chief Medical Officer Jones Mitchell Lawrence converted options into 131,167 shares and sold $106,536 worth of shares (51,880 units at $2.05), increasing direct ownership by 539% to 94,009 units (SEC Form 4) to satisfy tax liability
- CEO, CFO Finley John David exercised 335,300 shares at a strike of $0.00 and sold $303,343 worth of shares (146,798 units at $2.07), increasing direct ownership by 646% to 217,688 units (SEC Form 4) to cover withholding tax
- SEC Form 144 filed by Palisade Bio Inc.
- Director Baltera Robert Jr. bought $59,400 worth of shares (30,000 units at $1.98), increasing direct ownership by 9% to 366,904 units (SEC Form 4)
- Palisade Bio Receives FDA Clearance of IND for PALI-2108 and Plans to Initiate Global Phase 2 ASCENTRA-UC Study in Ulcerative Colitis
- Director Baltera Robert Jr. was granted 336,904 shares (SEC Form 4)
- SEC Form 3 filed by new insider Baltera Robert Jr.
Latest TIL
- SEC Form 4 filed by Director Mcgaughy R Kent Jr
- SEC Form 4 filed by Director Matcham George
- SEC Form 4 filed by Director Gibson Neil W
- SEC Form 4 filed by Director Binder Gwendolyn
- SEC Form 10-Q filed by Instil Bio Inc.
- Instil Bio Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
- SEC Form DEFA14A filed by Instil Bio Inc.
- SEC Form DEF 14A filed by Instil Bio Inc.
- Instil Bio Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits